About Slingshot Bioscience
Slingshot Bioscience is a company based in Berkeley (United States) founded in 2012. Slingshot Bioscience has raised $46.38 million across 3 funding rounds from investors including Arch Venture Partners, Anterra Capital and Northpond Ventures. The company has 46 employees as of December 31, 2024. Slingshot Bioscience offers products and services including TruCytes Biomarker Controls, ViaComp Cell Health Controls, SpectraComp Compensation Controls, FlowCytes Calibration Controls, and Custom TruCytes. Slingshot Bioscience operates in a competitive market with competitors including StemoniX, InterAx Biotech, ZoBio, Magnitude Biosciences and Signal Pharmaceuticals, among others.
- Headquarter Berkeley, United States
- Employees 46 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Slingshot Biosciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$46.38 M (USD)
in 3 rounds
-
Latest Funding Round
$11 M (USD), Series A
Feb 06, 2023
-
Investors
Arch Venture Partners
& 2 more
-
Employee Count
46
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Slingshot Bioscience
Slingshot Bioscience offers a comprehensive portfolio of products and services, including TruCytes Biomarker Controls, ViaComp Cell Health Controls, SpectraComp Compensation Controls, FlowCytes Calibration Controls, and Custom TruCytes.
Cell mimics for replicating biomarkers in assays.
Assess cell viability using DNA mimics.
Provide superior compensation for flow cytometry.
Ensure instrument calibration and traceability in research.
Tailored cell mimics for specific research needs.
People of Slingshot Bioscience
Unlock access to complete
Funding Insights of Slingshot Bioscience
Slingshot Bioscience has successfully raised a total of $46.38M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $11 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Slingshot Bioscience
Slingshot Bioscience has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Arch Venture Partners, Anterra Capital and Northpond Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked | |
|
Tech focused growth stage VC firm investing in Europe & North America
|
Locked | Locked | Locked | |
|
Venture capital firm investing in life sciences & tech sectors
|
Locked | Locked | Locked |
Investor details for Slingshot Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Slingshot Bioscience
Investment portfolio details for Slingshot Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Slingshot Bioscience
Detailed financials for Slingshot Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Slingshot Bioscience Comparisons
Peer comparison for Slingshot Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Slingshot Bioscience
Slingshot Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as StemoniX, InterAx Biotech, ZoBio, Magnitude Biosciences and Signal Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developing a commercial scale printer for the high-volume growth and differentiation of stem cells and stem cell products.
|
|
| Locked | Locked | Locked |
Mutated arrestins are employed as biosensors for GPCR drug discovery.
|
|
| Locked | Locked | Locked |
Provider of fragment-based drug discovery services
|
|
| Locked | Locked | Locked |
Cell-free in vitro assays are supplied to drug discovery firms.
|
|
| Locked | Locked | Locked |
Small molecule drugs regulating disease-associated genes are developed.
|
Detailed competitors of Slingshot Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Slingshot Bioscience
Complete news archive for Slingshot Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Slingshot Bioscience
Slingshot Bioscience was founded in 2012 and raised its 1st funding round 9 years after it was founded.
Slingshot Bioscience is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Slingshot Bioscience is a funded company, having raised a total of $46.38M across 3 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Slingshot Bioscience is 46.
Slingshot Bioscience was founded in 2012 in Berkeley, United States, within the bioscience sector. Synthetic cells are manufactured using patented technology to support research in diagnostics and therapeutics. Cell-like products, including FlowCytes, are produced to replicate optical, biochemical, and physical properties of natural cells. Operations focus on enabling advancements in these fields through innovative manufacturing processes.
Slingshot Bioscience's top competitors include Magnitude Biosciences, StemoniX and Sequence Bio.
Slingshot Bioscience offers TruCytes Biomarker Controls, ViaComp Cell Health Controls, SpectraComp Compensation Controls, FlowCytes Calibration Controls, and Custom TruCytes.
Slingshot Bioscience has 3 investors. Key investors include Arch Venture Partners, Anterra Capital, and Northpond Ventures.